2m 2m 2m 2m 2m 2m 2m
ACTUATE THERAP (ACTU)
NASDAQ
$0.28-$0.02 (-5.41%)
Price as of Nov 13, 2026 2:09 PM EST- $16.3MMarket Cap
- -94.97%1-Year Change
- BiotechnologyIndustry
ACTUATE THERAP (ACTU)
$0.28-$0.02 (-5.41%)
ACTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.30 | ||
Change | -$0.006 (-2.05%) | ||
Open | $0.33 | ||
High | $0.35 | ||
Low | $0.29 | ||
Previous Close | $0.30 | ||
Volume | 155,900 | ||
30-Day Average Volume | 506,953 | ||
1-Week Change | -9.48% | ||
1-Month Change | -54.02% | ||
1-Year Change | -94.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.0M | ||
Total Assets | $5.2M | ||
Market Cap | $16.3M | ||
Enterprise Value | $11.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$4.4M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $942,745.00 | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 16 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue